Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?

Trends in Pharmacological Sciences

Volumn 29, Issue 2, 2008, Pages 84-90

  Li, L ^a   Moore, P K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CYSTATHIONINE BETA LYASE; CYSTATHIONINE GAMMA LYASE; GLIBENCLAMIDE; HYDROGEN SULFIDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM DITHIONITE; TUMOR NECROSIS FACTOR ALPHA;

5' UNTRANSLATED REGION; AIR QUALITY; ALZHEIMER DISEASE; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CATABOLISM; DISEASE COURSE; DRUG ANTAGONISM; DRUG MECHANISM; ENZYME ACTIVITY; HEART PROTECTION; NEUROPROTECTION; NONHUMAN; PHYSICAL CHEMISTRY; POLLUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASODILATATION;

CARDIOVASCULAR SYSTEM; DRUG DELIVERY SYSTEMS; ENDOCRINE SYSTEM; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; NERVOUS SYSTEM;

EID: 38749105788     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.11.003     Document Type: Review

References (90)

1. Dombkowski R.A., et al. Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R678-R685
2. ATP channel opener. EMBO J. 20 (2001) 6008-6016
3. Richardson C.J., et al. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin. Chim. Acta 293 (2000) 115-125
4. Petersen L.C. The effect of inhibitors on the oxygen kinetics of cytochrome c oxidase. Biochim. Biophys. Acta 460 (1977) 299-307
5. Nicholson R.A., et al. Inhibition of respiratory and bioenergetic mechanisms by hydrogen sulfide in mammalian brain. J. Toxicol. Environ. Health A. 54 (1998) 491-507
6. Warenycia M.W., et al. Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels. Arch. Toxicol. 63 (1989) 131-136
7. Reiffenstein R.J., et al. Toxicology of hydrogen sulfide. Annu. Rev. Pharmacol. Toxicol. 32 (1992) 109-134
8. Mitsuhashi H., et al. Oxidative stress dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 24 (2005) 529-534
9. Geng B., et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem. Biophys. Res. Commun. 318 (2004) 756-763
10. Whiteman M., et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'?. J. Neurochem. 90 (2004) 765-768
11. Whiteman M., et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?. Biochem. Biophys. Res. Commun. 326 (2005) 794-798
12. Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Acids 26 (2004) 243-254
13. Robert K., et al. Expression of the cystathionine beta synthase (CBS) gene during mouse development and immunolocalization in adult brain. J. Histochem. Cytochem. 51 (2003) 363-371
14. Ishii I., et al. Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem. J. 381 (2004) 113-123
15. Mudd S.H., et al. Transsulfuration in mammals: microassays and tissue distribution of three enzymes in the pathway. J. Biol. Chem. 240 (1965) 4382-4392
16. 2S in rat tissues. Can. J. Physiol. Pharmacol. 81 (2003) 848-853
17. Levonen A.L., et al. Human cystathionine gamma-lyase: developmental and in vitro expression of two isoforms. Biochem. J. 347 (2000) 291-295
18. Li L., et al. Hydrogen sulfide is a novel mediator of endotoxic shock. FASEB J. 19 (2005) 1196-1198
19. Yusuf M., et al. Experimentally induced type 1 diabetes is associated with impaired hydrogen sulfide biosynthesis. Biochem. Biophys. Res. Commun. 333 (2005) 1146-1152
20. Bhatia M., et al. Role of hydrogen sulphide in acute pancreatitis in the mouse and rat. FASEB J. 19 (2005) 623-625
21. Ge Y., et al. Transcriptional regulation of the human cystathionine beta-synthase-1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3. Biochem. J. 357 (2001) 97-105
22. Prudova A., et al. S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6489-6494
23. Maclean K.N., et al. Cystathionine beta-synthase is coordinately regulated with proliferation through a redox-sensitive mechanism in cultured human cells and Saccharomyces cerevisiae. J. Cell. Physiol. 192 (2002) 81-92
24. 2S, a neuromodulator and smooth muscle relaxant. Nutr. Rev. 62 (2004) 348-353
25. Stipanuk M.H. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu. Rev. Nutr. 24 (2004) 539-577
26. Furne J., et al. Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem. Pharmacol. 62 (2001) 255-259
27. Picton R., et al. Mucosal protection against sulphide: importance of the enzyme rhodanese. Gut 50 (2002) 201-205
28. Hosoki R., et al. The possible relaxant effect of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 237 (1997) 527-531
29. Ali M.Y., et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?. Br. J. Pharmacol. 149 (2006) 625-634
30. Srilatha B., et al. Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J. Sex. Med. 4 (2007) 1304-1311
31. Cheng Y., et al. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2316-H2323
32. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42 (2005) 539-548
33. ATP channels. Basic Res. Cardiol. 101 (2006) 53-60
34. Teague B., et al. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br. J. Pharmacol. 137 (2002) 139-145
35. Kubo S., et al. Hydrogen sulfide causes relaxation in mouse bronchial smooth muscle. J. Pharmacol. Sci. 104 (2007) 362-392
36. 2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun. 313 (2004) 362-368
37. Zhu Y.Z., et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J. Appl. Physiol. 102 (2007) 261-268
38. Pan T.T., et al. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J. Mol. Cell. Cardiol. 40 (2006) 119-130
39. Sivarajah A., et al. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 26 (2006) 154-161
40. Hu Y., et al. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch. 455 (2007) 607-616
41. Elrod J.W., et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 15560-15565
42. Zagli G., et al. Hydrogen sulfide inhibits human platelet aggregation. Eur. J. Pharmacol. 559 (2007) 65-68
43. Shi Y.X., et al. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis and ROS production in SHR. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H2093-H2100
44. 2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. J. Biol. Chem. 279 (2004) 49199-49205
45. 2S on human aorta smooth muscle cells. FASEB J. 20 (2006) 553-555
46. Rinaldi L., et al. Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3. Lab. Invest. 86 (2006) 391-397
47. Meng Q.H., et al. Protective effect of hydrogen sulfide in balloon injury-induced neointima hyperplasia in rat carotid arteries. Am. J. Pathol. 170 (2007) 1406-1414
48. Cai W.J., et al. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc. Res. 76 (2007) 29-40
49. Yan S.K., et al. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 351 (2006) 485-491
50. Laggner H., et al. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic. Res. 41 (2007) 741-747
51. ATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle. Mol. Pharmacol. 68 (2005) 1757-1764
52. Olson K.R., et al. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic vasoconstriction and hypoxic vasodilation. J. Exp. Biol. 209 (2006) 4011-4023
53. Kubo S., et al. Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 232 (2007) 138-146
54. - dependent manner. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1953-H1960
55. Yan H., et al. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem. Biophys. Res. Commun. 313 (2004) 22-27
56. Konno R., et al. Nephrotoxicity of D-proparglyglycine in mice. Arch. Toxicol. 74 (2000) 473-479
57. Fiorucci S., et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 129 (2005) 1210-1224
58. Collin M., et al. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br. J. Pharmacol. 146 (2005) 498-505
59. Mok Y.Y.P., et al. Role of hydrogen sulfide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulfide biosynthesis. Br. J. Pharmacol. 143 (2004) 881-889
60. Li L., et al. Hydrogen sulfide - a novel mediator of inflammation. Curr. Opin. Pharmacol. 6 (2006) 125-129
61. Wallace J.L. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol. Sci. 28 (2007) 501-505
62. Qu K., et al. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 37 (2006) 889-893
63. Beyer K., et al. Cystathionine beta synthase as a risk factor for Alzheimer disease. Curr. Alzheimer Res. 1 (2004) 127-133
64. Cheung N.S., et al. Hydrogen sulfide induced neuronal death occurs via glutamate receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons. Neuropharmacology 53 (2007) 505-514
65. Kimura Y., et al. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid. Redox Signal. 8 (2006) 661-670
66. Kimura Y., and Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 18 (2004) 1165-1167
67. ATP channels. J. Pharmacol. Exp. Ther. 316 (2006) 325-335
68. Distrutti E., et al. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J. Pharmacol. Exp. Ther. 319 (2006) 447-458
69. Kawabata A., et al. Hydrogen sulfide as a novel nociceptive messenger. Pain 132 (2007) 74-81
70. Sjaastad O., and Bakketeig L.S. Hydrogen sulphide headache and other rare, global headaches: Vaga study. Cephalalgia 26 (2006) 466-476
71. 2S) stimulates capsaicin-sensitive primary afferent neurons in the rat urinary bladder. Br. J. Pharmacol. 142 (2004) 31-34
72. Trevisani M., et al. Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br. J. Pharmacol. 145 (2005) 1123-1131
73. Schicho R., et al. Hydrogen sulfide is a novel prosecretory neuromodulator in the guinea pig and human colon. Gastroenterology 131 (2006) 1542-1552
74. 2S in rat insulin-secreting cells and the underlying mechanisms. J. Physiol. 569 (2005) 519-531
75. Kaneko Y., et al. L-cysteine inhibits insulin release from the pancreatic beta-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter. Diabetes 55 (2006) 1391-1397
76. Yusuf M., et al. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem. Biophys. Res. Commun. 333 (2005) 1146-1152
77. Dello Russo C., et al. Evidence that hydrogen sulphide can modulate hypothalamo-pituitary-adrenal axis function: in vitro and in vivo studies in the rat. J. Neuroendocrinol. 12 (2000) 225-233
78. Li L., et al. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic. Biol. Med. 42 (2007) 706-719
79. Wallace J.L., et al. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology 132 (2007) 261-271
80. Fiorucci S., et al. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol. 150 (2007) 996-1002
81. Zanardo R.C., et al. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 20 (2006) 2118-2120
82. Wu X.C., and Zhang W.J. Using carbon nanotubes to absorb low concentration hydrogen sulfide in fluid. IEEE Trans. Nanobioscience 5 (2006) 204-209
83. Doeller J.E., et al. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal. Biochem. 341 (2005) 40-51
84. Bhatia M., et al. Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat. Br. J. Pharmacol. 145 (2005) 141-144
85. Zhang H., et al. Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury. J. Immunol. 179 (2007) 4153-4160
86. Zhang H., et al. Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis. J. Leukoc. Biol. 82 (2007) 894-905
87. Zhi L., et al. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-κB pathway. J. Leukoc. Biol. 81 (2007) 1322-1332
88. Wallace J.L., et al. Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 21 (2007) 4070-4076
89. Hu L.-F., et al. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen activated protein kinase in microglia. J. Neurochem. 100 (2006) 1121-1128
90. Oh G.S., et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic. Biol. Med. 41 (2006) 106-119